Tiede A, Collins P, Knoebl P, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020;105:1791–801.

Article  PubMed  PubMed Central  Google Scholar 

Zanon E, Acquired Hemophilia A. An update on the Etiopathogenesis, Diagnosis, and treatment. Diagnostics (Basel). 2023;13(3):420.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wong VW-S, Ekstedt M, Wong GL-H, et al. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79:842–52.

Article  PubMed  Google Scholar 

Shetty S, Sharma N, Ghosh K. Epidemiology of hepatocellular carcinoma (HCC) in hemophilia. Crit Rev Oncol Hematol. 2016;99:129–33.

Article  PubMed  Google Scholar 

Tsukagoshi M, Harimoto N, Araki K, et al. Laparoscopic hepatectomy for hepatocellular carcinoma in patients with hemophilia A and B: a report of two cases. Clin J Gastroenterol. 2023;16:884–90.

Article  PubMed  Google Scholar 

Shen SC, Harada A, Kurokawa T, et al. Partial hepatectomy for hepatocellular carcinoma in a patient with hemophilia: a case report. Hepatogastroenterology. 1994;41:283–6.

PubMed  CAS  Google Scholar 

Narushima Y, Ishiyama S, Kawashima K, et al. Operated hepatocellular carcinoma in two HIV- and HCV-positive hemophilic patients. J Hepatobiliary Pancreat Surg. 2004;11:207–10.

Article  PubMed  Google Scholar 

Jones AE, Roy A, Armstrong T, et al. Successful liver surgery in a haemophilia patient with high titre factor VIII inhibitor. Haemophilia. 2009;15:1332–3.

Article  PubMed  CAS  Google Scholar 

Inokawa Y, Sugimoto H, Kanda M, et al. Hepatectomy for hepatocellular carcinoma in patients with hemophilia. J Hepatobiliary Pancreat Sci. 2014;21:824–8.

Article  PubMed  Google Scholar 

Kobayashi K, Kokudo T, Yamaguchi T, et al. Hepatectomy in patients with inherited blood coagulation disorders can be safely performed with adequate coagulation factor replacement. Haemophilia. 2019;25:463–7.

Article  PubMed  CAS  Google Scholar 

Matsuda T, Umeda Y, Yoshida K, et al. Laparoscopic hepatectomy for the patient with hemophilia A with high titer factor VIII inhibitor. Acta Med Okayama. 2021;75:199–204.

PubMed  Google Scholar 

Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–90.

Article  PubMed  CAS  Google Scholar 

Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382:1894–905.

Article  PubMed  CAS  Google Scholar 

Song YG, Yeom KM, Jung EA, et al. Risk of bleeding in hepatocellular carcinoma patients treated with atezolizumab/bevacizumab: a meta-analysis. Cancers (Basel). 2024;16(14):2475.

Google Scholar 

Archibald WJ, Kouides PA, Refaai MA, Lachant NA. Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review. Blood Coagul Fibrinolysis. 2023;34:427–31.

Article  PubMed  Google Scholar 

Wolff L, Ertl C, Heinzerling L, et al. Acquired hemophilia due to immune checkpoint inhibitors: a case series introducing Emicizumab treatment and literature review. Oncologist. 2025;30:oyaf260.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Giangrande PLF, Hermans C, O’Mahony B, et al. European principles of inhibitor management in patients with haemophilia. Orphanet J Rare Dis. 2018;13:66.

Article  PubMed  PubMed Central  CAS  Google Scholar